Table 5 Characteristics of the six HBV/HCV dually infected patients.
Patient | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
Age (years) | 20 | 36 | 21 | 37 | 35 | 34 |
Sex | M | M | M | M | M | M |
Baseline ALT (× ULN) | 1.5 | 1 | 1.5 | 1 | 1 | 1 |
Duration of HCV Infection (years) | 1 | 13 | 2 | 12 | 2 | 2 |
PostTreatment ALT (× ULN) | 1 | 1 | 1 | 1 | 0.5 | 0.5 |
COBAS HBV DNA Level (IU/ml) | 2980 | 2210 | 2880 | 2010 | 128 | 149 |
Serological Status | ||||||
Anti-HBc | -ve | +ve | -ve | +ve | -ve | -ve |
Anti-HBs | -ve | -ve | -ve | -ve | -ve | -ve |
METAVIR Score | ||||||
Activity (A) | A2 | A2 | A2 | A2 | A1 | A1 |
Fibrosis (F) | F2 | F2 | F2 | F2 | F2 | F2 |
Basal HCV Load (IU/ml) | 0.4 × 105 | 22.3 × 105 | 0.39 × 105 | 22.1 × 105 | 7.2 × 105 | 7.23 × 105 |
Post-Treatment HCV Load (IU/ml) | 1.4 × 105 | 6 × 105 | 1.38 × 105 | 5.59 × 105 | 0.0028 × 105 | 0.027 × 105 |
Response to IFN | NR | NR | NR | NR | RR | RR |